Australia is a compelling destination to develop, commercialise, scale and
source the next generation of digital health technologies.
We have a strong track record in health. As the inventors of the Cochlear
implant, spray-on skin, the cervical cancer vaccine and a cure for peptic
ulcers, Australian health and medical research is changing lives for the
Australia has embraced digital health to provide new ways of delivering
services and to radically transform current processes, improve outcomes and
increase efficiencies, creating opportunities for collaboration and
The Australian Government is continuing to invest in digital health
infrastructure, and notable projects include:
- A National Digital Health Strategy, with pioneering initiatives
co-produced between consumers, governments, researchers, providers and
industry. This includes a framework for secondary data use
- My Health Record, a personally controlled electronic health record
covering over 90% of Australian residents
The $20 billion Medical Research Future fund, the largest endowment fund
of its kind in the world.
62% of Australians are using technology to better manage their health. 91%
believe technology can help them better manage their health. 
A world-leading healthcare environment
As a market to develop new digital health solutions, or a launchpad into
Southeast Asia, Australia is an ideal place to do business. There are more
than 30 incubators and accelerators across the country, with ANDHealth providing a dedicated
ecosystem for the development and commercialisation of evidence-based
digital health products.
Supported by a highly skilled and technology-driven workforce and backed by
leading research institutions, Australian expertise across medtech and
health is world class.
Australia has been ranked first in the developed world for health care
outcomes and administrative efficiency and second overall for our
healthcare system by the Commonwealth Fund. Our healthcare system delivers
long life expectancy at a low cost - just US$4,207 per capita, compared
with US$9,364 for the US. 
Our leadership of the Global Digital Health Partnership, a
collaboration of 23 countries and the World Health Organisation, reflects
our commitment to and excellence in digital health.
Australia’s digital health market, valued at US$1.488 billion in 2017, is
expected to grow to US$1.851 billion in 2020. 
Opportunities for collaboration
The Australian Digital Health Agency’s
National Digital Health Strategy 2018–2022
proposes a number of pioneering initiatives co-produced between consumers,
governments, researchers, providers and industry.
Opportunities for international expertise include:
- Investing in the integrated management of chronic illness
Developing new digital services to support the health of babies and young
Improving digital services for advanced care planning
Improving information sharing in urgent and emergency care
Widening access to telehealth services, particularly in rural and
Global investment pathways
Australia provides a unique opportunity for investors to trial solutions
here or grow existing businesses, then leverage international regulatory
compatibility to enter global markets. In addition, Australia’s numerous
Free Trade Agreements ensure enhanced access to key markets.
Examples of global digital health research collaboration in Australia include:
- US conglomerate Johnson & Johnson has opened an
Innovation Partnering Office at Monash University in Victoria.
is the Victorian headquarters for Johnson & Johnson’s scientific,
investment and commercialisation arms and identifies medtech projects for
potential collaboration and commercialisation.
Fujifilm Medical Systems
partnered with Alcidion to develop an
intelligent cardiovascular information system
that delivers advanced decision support to cardiovascular clinicians.
IP Group plc, a UK-based intellectual property (IP) commercialisation company, has
committed to invest at least $200 million over a 10-year period to
fund investments in spin-out companies based on the IP developed by
academics at eight Australian universities, generated from research in
areas such as digital medicine, new medical therapies and quantum
Tap into government funding and tax rebates
The Australian Government supports productive foreign investment partners
Medical Research Future Fund
($20 billion endowment by 2020) to collaborate with Australian
Foreign investment partners can also access the
Biomedical Translation Fund
($500 million) to co-invest in emerging Australian biomedical companies
with licensed Australian venture capital firms.
Research and development (R&D) tax rebates
as well as Australians’ enviable lifestyle helps attract and retains
world-class talent, which in turn can help your business achieve its goals
in this region.
 Australia Speaks 2018
The Commonwealth Fund.
Mirror, Mirror 2017: International Comparison Reflects Flaws and
Opportunities for Better U.S. Health Care. July 14, 2017. Eric C.
Schneider, M.D., Dana O. Sarnak, David Squires, Arnav Shah, and Michelle M.
 Frost and Sullivan. Global Digital health Outlook 2018
Australian Digital Health Agency,
Australia’s National Digital Health Strategy: Safe, Seamless and Secure
, July 2018, accessed 11 January 2019.
IP Group plc - Commits A$200m in landmark deal with 9 leading universities in Australia and New Zealand